In this issue:
Mobilizing stem cells for ASCT
PERCEPT trial of prehabilitation for ASCT
CAR T-cell therapy with idecabtagene vicleucel
Management of RRMM in the era of advanced therapies
Current advances in the management of MM
Patient preferences during treatment decision making
Assessment of fitness in newly-diagnosed MM
CAR NK-cell therapy for haematological malignancies
Practice guidelines for the prevention of infection
High-dose melphalan and mutational burden
Delivery system for bortezomib
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)